SCHEMBL4123059

SCHEMBL4123059

CCCc1nn(CC)c2c(=O)[nH]c(N(Cc3cccc(N4CCOCC4)c3)CC3CCCCC3)nc12

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 8/20 0.34
HDAC1 Q13547 4/20 0.34
HDAC6 Q9UBN7 4/20 0.34
HDAC2 Q92769 1/20 0.33
TPH1 P17752 2/20 0.33
TPH2 Q8IWU9 2/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
PDE6C P51160 1/20 0.32
ATM Q13315 5/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
PIK3C3 Q8NEB9 3/20 0.32
PRKDC P78527 1/20 0.32
USP2 O75604 1/20 0.32
GAA P10253 1/20 0.32
TTK P33981 1/20 0.32
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4128912 0.91 PDE5A (0.41) PDE5AHDAC1HDAC6HDAC2PDE6C
SCHEMBL4133677 0.89 TPH1 (0.33) TPH1TPH2HCRTR1HCRTR2ATM
SCHEMBL8032543 0.85 HSP90AA1 (0.35) HCRTR1HCRTR2ATMPIK3C3PRKDC
SCHEMBL8032549 0.83 PDE5A (0.36) PDE5AHDAC1HDAC6HDAC2PDE6C
SCHEMBL4128842 0.81 KDM4E (0.35) TPH1TPH2HCRTR1HCRTR2ATM
SCHEMBL4136646 0.81 PDE5A (0.43) PDE5AHDAC1HDAC6HDAC2PDE6C
SCHEMBL8037857 0.80 PDE5A (0.42) PDE5AHDAC1HDAC6HDAC2PDE6C
SCHEMBL8039488 0.79 PDE5A (0.39) PDE5AHDAC1HDAC6HDAC2PDE6C
SCHEMBL4901484 0.79 PDE5A (0.42) PDE5AHDAC1HDAC6HDAC2PDE6C
SCHEMBL4901618 0.77 PDE5A (0.41) PDE5AHDAC1HDAC6HDAC2PDE6C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed